We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Solving POC Test Communication Challenges to EMRs

By LabMedica International staff writers
Posted on 02 Dec 2009
According to a leading healthcare market research publisher, a key question users of glucose monitors and other point-of-care (POC) tests may ask is "does the POC test talk to the user's electronic medical record (EMR).” As wireless communication becomes standard in hospitals, it is incumbent on the US$13 billion worldwide market for POC test systems to participate fully in this phenomenon. More...


Connectivity is a high priority issue in order for hospital POC testing and critical care device markets to expand, according to the findings of a recent market report from healthcare market research publisher Kalorama Information (New York, NY, USA). "On-the-spot access to patient information and care guidelines is part of the healthcare quality imperative of the 21st century,” noted Shara Rosen, Kalorama Information's diagnostics analyst. "Cost reduction pressures and the need for shortened in-patient stays are promoting the use of wireless communication in and out of hospitals.”

While the worldwide medical community is racing to embrace EMR and telemedicine, most POC test devices currently have limited connectivity capabilities and cannot participate. At this time, all major lab-based instruments interface automatically to a laboratory information system (LIS) or hospital information system (HIS) system. However, many glucose monitors in hospital wards do not have this connectivity capability and so they do not become part of a patient's EMR. The same applies to almost all pregnancy and urinalysis tests performed in the hospital but outside the laboratory.

Within today's hospital environment of limited resources, cost pressures, decentralized patient information, large investment in new technologies and increased regulatory scrutiny, healthcare is more challenging than ever before. POC testing is poised to provide a solution to some of these economic pressures. However, without first-class connectivity solutions, POC testing cannot provide the expected benefits in improved patient care that will lead to cost reductions. "Any manufacturers who want to make their POC products incredibly valuable should make sure they can link up with major EMR systems,” said Ms. Rosen.

Beyond the connectivity issue, the next frontier is continuous monitoring of patients in acute care and in selected treatment areas such as dialysis, intensive care, and the operating room (OR). Moreover, as the number of POC tests continues to grow, potential users will not want to learn to use a large number of devices. Therefore, considerable research has been ongoing for about a decade on a multipurpose POC platform that can run chemistries and immunoassays.

Kalorama Information supplies independent market research in the life sciences, as well as a full range of custom research services.

Related Links:
Kalorama Information


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image

FDA Breakthrough-Designated Urine Panel Aims to Shorten Pathogen and Susceptibility Testing

Urinary tract infections are among the most common bacterial infections and a major driver of antibiotic prescribing, yet culture-based workflows can take days to produce results. Treatment often begins... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.